Clinical Trials

Breast Neoplasms

NCT02468024 2026-03-18

STABLE-MATES

272 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04902040 2026-03-18

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Phase 1/2 Terminated

19 enrolled 11 charts

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Lung Neoplasms

NCT05941741 2026-03-18

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

380 enrolled

Nasopharyngeal Carcinoma

NCT01612351 2026-03-17

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

Phase 2 Completed

40 enrolled 20 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT02114229 2026-03-17

SJATRT

125 enrolled

Rhabdoid Tumor

NCT04732065 2026-03-17

PNOC023

208 enrolled

Phase 1 Active not recruiting

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

NCT05813327 2026-03-17

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

6 enrolled

Sarcoma

Sarcoma, Ichthyosis, X-Linked

NCT06934889 2026-03-17

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

60 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT07282483 2026-03-17

Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients

Phase 3 Active not recruiting

118 enrolled

Other

Radiation-induced Oral Mucositis

NCT07477626 2026-03-17

RADVAN

374 enrolled

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT07478679 2026-03-17

Radiation to Treat Joint Damage Caused by Cancer Immunotherapy

20 enrolled

Arthritis, Joint Diseases

NCT03274687 2026-03-16

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Phase 3 Completed

296 enrolled 29 charts

Prostate Adenocarcinoma

NCT05950594 2026-03-16

IVIM & OLINK in Sarcoma

145 enrolled

Sarcoma

NCT07245745 2026-03-16

Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer

188 enrolled

Prostatic Neoplasms

NCT03875716 2026-03-13

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

111 enrolled

Phase 2 Not yet recruiting

Head and Neck Neoplasms

NCT05521997 2026-03-13

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

42 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02287428 2026-03-12

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

56 enrolled

Phase 2 Not yet recruiting

Glioblastoma

NCT07467590 2026-03-12

TRIUNITE-07

33 enrolled

Colorectal Neoplasms

NCT03313804 2026-03-11

Priming Immunotherapy in Advanced Disease With Radiation

Phase 2 Completed

76 enrolled 9 charts

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

NCT03968406 2026-03-11

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

24 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT06504381 2026-03-11

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Phase 1/2 Recruiting

70 enrolled

Phase 1/2 Active not recruiting

Glioma

NCT02402920 2026-03-10

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Phase 1 Completed

83 enrolled 13 charts

EndocrineNET

Neuroendocrine Tumors

NCT04454528 2026-03-10

BreastVAX

27 enrolled

Breast Neoplasms

NCT06954623 2026-03-10

BREAST

20 enrolled

Phase NA Not yet recruiting

Breast Neoplasms

NCT07461142 2026-03-10

RETHEMCOL

72 enrolled

Gynecologic

Cervical Cancer by FIGO Stage 2018

NCT05076513 2026-03-09

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

Phase EARLY_PHASE1 Active not recruiting

42 enrolled

Glioblastoma, Glioma

NCT05986318 2026-03-09

RESPIRE-ILD

98 enrolled

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

NCT06483308 2026-03-09

SHiP-Rt

37 enrolled

Phase 1 Not yet recruiting

Lung Neoplasms

NCT07457307 2026-03-09

INSIGHT MRL

20 enrolled

Phase NA Active not recruiting

Glioma

NCT01428895 2026-03-06

Femoral Bone Metastases

180 enrolled

Tumor-Agnostic

Neoplasms

NCT02959463 2026-03-06

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

Phase 1 Active not recruiting

24 enrolled 11 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03322267 2026-03-06

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

Phase 2 Completed

26 enrolled 6 charts

Esophageal Squamous Cell Carcinoma

NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

NCT03028337 2026-03-05

Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases

80 enrolled

CNSOther neoplasm

Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System

NCT03359954 2026-03-05

Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer

25 enrolled

Estrogen Receptor Positive

NCT04170946 2026-03-05

Talazoparib

24 enrolled

Phase 1 Active not recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04522336 2026-03-05

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

16 enrolled

Phase 3 Not yet recruiting

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

NCT07452458 2026-03-05

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

398 enrolled

Phase 2 Not yet recruiting

Glioblastoma

NCT06813664 2026-03-04

CURB-TKI

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06823375 2026-03-04

SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis

40 enrolled

HCC

NCT06992427 2026-03-04

HOPE

228 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07448142 2026-03-04

Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer

50 enrolled

Colorectal Neoplasms

NCT05050162 2026-03-03

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Phase 2/3 Suspended

1,714 enrolled

Carcinoma, Oropharyngeal Neoplasms

NCT06208826 2026-03-03

A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy

268 enrolled

Head and Neck Neoplasms

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

47 enrolled

Small Cell Lung Carcinoma

NCT06434350 2026-03-02

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

Phase 1/2 Recruiting

41 enrolled

Advanced Bladder Cancer

NCT07026474 2026-03-02

RePaIr-HN

214 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06558981 2026-02-27

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

124 enrolled

Thyroid Neoplasms

NCT06719440 2026-02-27

BELGICA

347 enrolled